Serum Institute of India
Indian biotechnology and biopharmaceuticals company
Follow Serum Institute of India on Notably News to receive short updates to your email — rarely!
| October 8 2023 | The R21/Matrix-M malaria vaccine received a recommendation for use by the WHO's Strategic Advisory Group of Experts (SAGE) and the Malaria Policy Advisory Group (MPAG). |
| July 13 2021 | RDIF announced that Serum Institute of India would start production of Sputnik V vaccine doses in September 2021, with plans to produce over 300 million doses annually in India. |
| March 2021 | An agreement was reached to supply Covishield vaccine doses to the UK. |
| March 2021 | Reuters reported that the Chinese state-backed cyber-espionage group Red Apollo targeted Serum Institute of India's intellectual property for exfiltration. |
| December 2020 | Serum Institute of India sought emergency approval for the Covishield vaccine developed with AstraZeneca. |
| September 2020 | COVID-19 vaccine trials for AZD1222 (Covishield) were temporarily halted by DCGI after a volunteer in Oxford developed an illness following vaccination, but were soon resumed after British regulators' consent. |
This contents of the box above is based on material from the Wikipedia article Serum Institute of India, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.